Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2012
06/12/2012CA2495294C Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines
06/12/2012CA2413251C Compositions and methods to improve the oral absorption of antimicrobial agents
06/12/2012CA2404325C Immunotherapeutic methods and compositions
06/07/2012WO2012075379A2 Liquid viral formulations
06/07/2012WO2012075376A2 Lyophilized viral formulations
06/07/2012WO2012075362A2 Chemokine cxcr4 receptor modulators and used related thereto
06/07/2012WO2012075361A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/07/2012WO2012075257A2 Compositions for oral and nasal hygiene
06/07/2012WO2012075235A1 Alkyl amides as hiv attachment inhibitors
06/07/2012WO2012075140A1 Compounds
06/07/2012WO2012074490A1 Control of bacterial growth
06/07/2012WO2012074116A1 IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH α CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM Vα-Jα, AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS
06/07/2012WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound
06/07/2012WO2012073856A1 Oil-in-water emulsion composition containing difluprednate and tobramycin
06/07/2012WO2012073214A2 New heptose derivatives and biological applications thereof
06/07/2012WO2012073138A1 Monobactams
06/07/2012WO2012072655A1 New treatments of hepatitis c virus infection
06/07/2012WO2012072200A1 3-hetaryl-substituted pyrrolo[2,3-b]pyridine derivatives as pdk1 inhibitors
06/07/2012WO2012071684A1 Heterocyclic derivates，preparation processes and medical uses thereof
06/07/2012WO2012036523A3 Novel antibiotically active compound and an antibiotic composition comprising the compound
06/07/2012WO2012036518A3 Novel antibiotically active compound and an antibiotic composition comprising the compound
06/07/2012WO2012036507A3 Aptazyme specifically releasing antisense against microrna in hcv-infected cells, and use thereof
06/07/2012WO2012009774A3 Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods
06/07/2012WO2012007776A3 Disinfectant and antiseptic formulation having reduced iodine content
06/07/2012WO2011159814A3 Novel live recombinant booster vaccine against tuberculosis
06/07/2012WO2011159071A3 Peptide having antimicrobial or anti-inflammatory activity and pharmaceutical composition containing same as an active ingredient
06/07/2012US20120144509 Novel strains of helicobacter pylori and uses thereof
06/07/2012US20120142778 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids
06/07/2012US20120142752 Hiv protease inhibitors
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142731 Methods of inhibiting viral infection
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142711 Acid-labile trigger units
06/07/2012US20120142710 Ketolide Compounds Having Antimicrobial Activity
06/07/2012US20120142707 Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142701 Compounds and methods for the treatment of proliferative diseases
06/07/2012US20120142686 Viral polymerase inhibitors
06/07/2012US20120142682 Antivirulence compounds inhibiting bacterial mono-adp-ribosyltransferase toxins
06/07/2012US20120142653 C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142637 Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1h)- one and derivatives thereof
06/07/2012US20120142636 Novel glucokinase activators and methods of using same
06/07/2012US20120142635 Oxazolidinone-quinolone hybrid antibiotics
06/07/2012US20120142627 Monophosphate prodrugs of dapd and analogs thereof
06/07/2012US20120142626 Compounds
06/07/2012US20120142623 Compositions And Methods For Predicting Inhibitors Of Protein Targets
06/07/2012US20120142622 Stambomycin and derivatives, their production and their use as drugs
06/07/2012US20120142621 Purified Ethyl Ester Sophorolipid for the Treatment of Sepsis
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142617 Antiviral therapeutic agents
06/07/2012US20120142612 Cytokine protein family
06/07/2012US20120142611 Repeat protein from collection of repeat proteins comprising repeat modules
06/07/2012US20120142584 Novel transporter constructs and transporter cargo conjugate molecules
06/07/2012US20120142583 Methods of inhibiting and treating bacterial biofilms by metal chelators
06/07/2012US20120142071 Thymidine Kinase Mutants
06/07/2012US20120141609 Melt-Blended Protein Composition
06/07/2012US20120141608 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as anthrax, virus or radiation and use in combination with dhea for the treatment of viruses
06/07/2012US20120141602 Systems containing magnetic nanoparticles and polymers, such as nanocomposites and ferrofluids, and applications thereof
06/07/2012US20120141588 Dentifrice compositions containing calcium silicate and a basic amino acid
06/07/2012US20120141585 Immunomodulatory compositions comprising a polymer matrix and an oil phase
06/07/2012US20120141574 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof
06/07/2012US20120141565 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications
06/07/2012US20120141542 Method of using punicic acid to enhance immune response and prevent metabolic disorders
06/07/2012US20120141541 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
06/07/2012US20120141540 Drug Delivery System
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141537 Enhancing t cell activation using altered mhc-peptide ligands
06/07/2012US20120141534 Vault Compositions for Immunization Against Chlamydia Genital Infection
06/07/2012US20120141531 Composition comprising oil drops
06/07/2012US20120141529 Norovirus and sapovirus antigens
06/07/2012US20120141528 Lyophilized viral formulations
06/07/2012US20120141527 Structured viral peptide compositions and methods of use
06/07/2012US20120141526 Nanoemulsion vaccines
06/07/2012US20120141525 Universal influenza vaccine based on recombinant modified vaccine ankara virus (mva)
06/07/2012US20120141523 Immunogenic composition comprising antigenic s. aureus proteins
06/07/2012US20120141522 Recombinant protective protein from streptococcus pneumoniae
06/07/2012US20120141521 Immunogenic Compositions for Streptococcus agalactiae
06/07/2012US20120141520 Recombinant subunit west nile virus vaccine for protection of human subjects
06/07/2012US20120141519 Reagents and methods for detecting influenza virus proteins
06/07/2012US20120141518 Human Parvovirus: Bocavirus
06/07/2012US20120141516 Compositions and methods for inducing an immune response
06/07/2012US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/07/2012US20120141503 Heavy Chain and Domain Antibodies
06/07/2012US20120141502 Antibodies specific to e6 proteins of hpv and use thereof
06/07/2012US20120141493 Human binding molecules having killing activity against staphylococci and uses thereof
06/07/2012US20120141491 Methods and compositions for the treatment of cancers and pathogenic infections
06/07/2012US20120141482 Molecular complexes which modify immune responses
06/07/2012US20120141470 T cell inhibitory receptor compositions and uses thereof
06/07/2012US20120141458 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
06/07/2012US20120141457 Lateral Flow Immunoassay for Complement Activation and Methods of Use for Point-of-Care Assessment of Complement-Associated Disorders
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141426 Reovirus for the Treatment of Cellular Proliferative Disorders
06/07/2012US20120141423 Novel paenibacillus polymyxa strain, antibiotic antimicrobial agents and methods of their use
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141414 Bimacrocylic HCV NS3 Protease Inhibitors
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
1 ... 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 ... 1798